Company: ALCE
Filing Date: 2025-12-08
Form Type: DEF 14C
Source: 0001213900-25-118968
Chunk: 16

Company: Alternus Clean Energy, Inc.
Filing Date: 2025-12-08
Form: DEF 14C
Chunk 16
---
 Venture Management, 
 Inc., a company owned and controlled by Mr. Parker.             |

| (5) | Alternus Energy Group Plc, Suite 9/10 Blanchardstown Corporate 
 Park 2, Blanchardstown, Dublin, Ireland D15.                   |

| (6) | BVP Investments Limited, Unit 4 Aspen Court, Bray Road, Cornelscourt, 
 Dublin, Ireland 7.                                                    |

| (7) | Vincent Collins, Beechwood, Roscommon, Co Roscommon, Ireland, 
 F42 FD77.                                                     |

<div align='center'>7

INTERESTS OF CERTAIN PERSONS IN OR OPPOSITION TO MATTERS TO BE ACTED UPON</div>

None of the persons who have served as our officers
or directors since the beginning of our last fiscal year, or any associates of such persons, have any substantial interest, direct or
indirect, in the authorization and approval of the Reverse Stock Split, other than the interests held by such persons through their respective
beneficial ownership of the shares of our capital stock set forth above in the section entitled “Security Ownership of Certain Beneficial
Owners and Management.” None of our directors opposed the authorization and approval of the Private Placement.

<div align='center'>VOTE OBTAINED — DELAWARE LAW</div>

Section 228 of the DGCL generally provides
that any action required to be taken at a meeting of stockholders may be taken without a meeting, without prior notice and without a vote,
if a written consent thereto is signed by stockholders having not less than the minimum number of votes that would be necessary to authorize
or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Pursuant to the Listing Rules of
OTC Pink tier of the over -the-counter market operated by OTC Markets Group, Inc., a majority of the outstanding voting shares of stock
entitled to vote thereon is required in order to effectuate FINRA Approval. In order to eliminate the costs and management time involved
in obtaining proxies and to effect the above action as early as possible in order to accomplish the purposes of the Company as herein
described, the Board consented to the utilization of, and successfully obtained, written consent of the Majority Stockholder.

As of the Record Date, there were 600,724,658
shares of voting stock outstanding, with 724,658 shares being Common Stock and 60,000 shares of Series A